SCHEMBL285786

SCHEMBL285786

Cc1ccccc1CCCCO

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.54
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
LIPG Q9Y5X9 1/20 0.41
CHRM2 P08172 1/20 0.41
CYP4F2 P78329 1/20 0.41
CYP4A11 Q02928 1/20 0.41
GPR84 Q9NQS5 1/20 0.40
DAO P14920 2/20 0.39
SLC16A3 O15427 1/20 0.39
TP53 P04637 1/20 0.38
GBA1 P04062 1/20 0.38
HPGD P15428 2/20 0.38
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27994627 0.98 TAAR1 (0.52) TAAR1CA12CA1CA2CA7
SCHEMBL12330373 0.98 TAAR1 (0.52) TAAR1CA12CA1CA2CA7
SCHEMBL12330840 0.98 TAAR1 (0.52) TAAR1CA12CA1CA2CA7
Water SCHEMBL9249275 0.98 TAAR1 (0.52) TAAR1CA12CA1CA2CA7
SCHEMBL8055122 0.98 TAAR1 (0.52) TAAR1CA12CA1CA2CA7
SCHEMBL29707636 0.98 TAAR1 (0.52) TAAR1CA12CA1CA2CA7
Alcohol SCHEMBL27261466 0.96 TAAR1 (0.50) TAAR1CA12CA1CA2CA7
SCHEMBL29493080 0.93 TAAR1 (0.56) TAAR1CA12CA1CA2CA7
SCHEMBL80017 0.93 TAAR1 (0.56) TAAR1CA12CA1CA2CA7
Water SCHEMBL29017465 0.91 TAAR1 (0.54) TAAR1CA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 268 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250275917-A1 TOPICAL FOAMABLE PHARMACEUTICAL COMPOSITION EUROFARMA LABORATORIOS S.A. (BR) 2025-09-04 US claimed
EP-4282418-A9 FOAMING TOPICAL PHARMACEUTICAL COMPOSITION Eurofarma Laboratórios S.A. (BR) 2024-07-17 EP claimed
CN-115672296-B Preparation and application of phenylalanine modified short-chain column [5] arene chiral chromatographic packing 中国科学院兰州化学物理研究所 2024-01-26 CN claimed
EP-4282418-A1 FOAMING TOPICAL PHARMACEUTICAL COMPOSITION Eurofarma Laboratórios S.A. (BR) 2023-11-29 EP claimed
WO-2023129114-A1 OBTAINING THEBAINE FROM THEBAINE-RICH POPPY CAPSULE BY USING THE METHOD OF ALCOHOL EXTRACTION TOPRAK MAHSULLERİ OFİSİ GENEL MÜDÜRLÜĞÜ (TR) 2023-07-06 WO claimed
WO-2022178604-A1 FOAMING TOPICAL PHARMACEUTICAL COMPOSITION EUROFARMA LABORATORIOS S.A. (BR) 2022-09-01 WO claimed
CN-108084325-B Preparation of acrylic resin and application of acrylic resin in antifouling paint 浙江海洋大学 2021-03-30 CN claimed
EP-2554054-A1 Process for preparing a fraction enriched with ginkgo terpenes INDENA S.p.A. (IT) 2013-02-06 EP claimed
EP-1647262-B2 Anhydrous cosmetic composition comprising electrophilic monomers and acid, and use for cosmetic treatment of hair OREAL (FR) 2012-02-08 EP claimed
EP-1455738-B1 USE OF ELECTROPHILIC MONOMERS FOR HAIR TREATMENT OREAL (FR) 2010-07-28 EP claimed
US-20060088493-A1 Composition and process for the cosmetic treatment of keratin materials based on electrophilic monomers and non-silicone polymers L'OREAL S.A. (FR) 2006-04-27 US claimed
CN-1762327-A Use for the cosmetic treatment of keratinous material of not sticky compositions based on electrophilic monomers and non-silicon polymers OREAL (FR) 2006-04-26 CN claimed
US-20060083706-A1 Haircare composition comprising at least one electrophilic monomer and micro- or nanoparticles of at least one solid lubricant L'OREAL S.A. (FR) 2006-04-20 US claimed
US-20060083762-A1 Uses of compositions comprising electrophilic monomers and micro-particles or nanoparticles L'OREAL S.A. (FR) 2006-04-20 US claimed
US-20060080792-A1 Film-forming composition for the cosmetic treatment of keratin materials comprising at least one electrophilic monomer and at least one non-silicone polymer L'OREAL S.A. (FR) 2006-04-20 US claimed
US-20060078523-A1 Composition comprising at least one electrophilic monomer and at least one acid in a cosmetically acceptable anhydrous medium, and use thereof for cosmetic treatment of the hair L'OREAL S.A. (FR) 2006-04-13 US claimed
US-20060078522-A1 Composition for treating keratin materials comprising at least one electrophilic monomer and at least one salt L'OREAL S.A. (FR) 2006-04-13 US claimed
US-20030175229-A1 Electrophilic monomers for treating the hair L'OREAL (FR) 2003-09-18 US claimed
EP-0225785-A2 Preparation of mono-disperse metal oxides AKZO N.V. (NL) 1987-06-16 EP claimed
US-4204987-A Aqueous polyester dispersion for adhering vinyl film to wood THE GOODYEAR TIRE & RUBBER COMPANY (US) 1980-05-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060088493-A1 Composition and process for the cosmetic treatment of keratin materials based on electrophilic monomers and non-silicone polymers KRT18, CUTA, MARK1 TAAR1 3929/4885CA12 3395/4885CA1 3524/4885
US-20060083762-A1 Uses of compositions comprising electrophilic monomers and micro-particles or nanoparticles KRT18, PRKDC, ACP1 TAAR1 3397/4885CA12 1912/4885CA1 2181/4885
US-20030175229-A1 Electrophilic monomers for treating the hair NACA, SUCLG1, TYR TAAR1 2734/4885CA12 2289/4885CA1 3291/4885
US-20060083706-A1 Haircare composition comprising at least one electrophilic monomer and micro- or nanoparticles of at least one solid lubricant MITF, CUTA, NACA TAAR1 748/4885CA12 3938/4885CA1 3873/4885
US-20060078523-A1 Composition comprising at least one electrophilic monomer and at least one acid in a cosmetically acceptable anhydrous medium, and use thereof for cosmetic treatment of the hair HOGA1, OAT, SUCLG1 TAAR1 1219/4885CA12 705/4885CA1 841/4885
US-20060078522-A1 Composition for treating keratin materials comprising at least one electrophilic monomer and at least one salt KRT18, DSG1, DSC1 TAAR1 2401/4885CA12 720/4885CA1 787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.